{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T22:31:27Z","timestamp":1788993087406,"version":"build-2803163510"},"reference-count":27,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2010,9,9]],"date-time":"2010-09-09T00:00:00Z","timestamp":1283990400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0012640","type":"journal-article","created":{"date-parts":[[2010,9,9]],"date-time":"2010-09-09T20:47:56Z","timestamp":1284065276000},"page":"e12640","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":69,"title":["The Antipsychotic Thioridazine Shows Promising Therapeutic Activity in a Mouse Model of Multidrug-Resistant Tuberculosis"],"prefix":"10.1371","volume":"5","author":[{"given":"Dick","family":"van Soolingen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rogelio","family":"Hernandez-Pando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector","family":"Orozco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecile","family":"Magis-Escurra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard","family":"Amaral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakko","family":"van Ingen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin J.","family":"Boeree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2010,9,9]]},"reference":[{"key":"ref1","first-page":"317","article-title":"Experiments to illustrate the effect of chlorpromazine on the permeability of the bacterial cell wall.","volume":"87","author":"JE Kristiansen","year":"1979","journal-title":"Acta Pathol Microbiol Scand (B)"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/jac\/47.5.505","article-title":"Activity of phenothiazines against antibiotic-resistant <italic>Mycobacterium tuberculosis<\/italic>: a review supporting further studies that may elucidate the potential use of thioridazine as antituberculosis therapy.","volume":"47","author":"L Amaral","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"ref3","article-title":"Anti-tuberculosis drug resistance in the World.","year":"2008"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1086\/518663","article-title":"New tuberculosis therapeutics: a growing pipeline.","volume":"196","author":"MK Spigelman","year":"2007","journal-title":"J Infect Dis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1056\/NEJMoa0808427","article-title":"The diarylquinoline TMC207 for multidrug-resistant tuberculosis.","volume":"360","author":"AH Diacon","year":"2009","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1128\/AAC.47.3.917-922.2003","article-title":"Clinical concentrations of thioridazine kill intracellular multidrug-resistant <italic>Mycobacterium tuberculosis<\/italic>.","volume":"47","author":"D Ordway","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ijantimicag.2009.02.015","article-title":"In vitro activity of thioridazine against mycobacteria.","volume":"34","author":"J van Ingen","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1086\/422532","article-title":"Increased IL-4 production by CD8 and gammadelta T cells in health care workers is associated with the subsequent development of active tuberculosis.","volume":"190","author":"D Ordway","year":"2004","journal-title":"J Infect Dis"},{"key":"ref9","first-page":"26","article-title":"Correlation between the kinetics of Th1\/Th2 cells and pathology in a murine model of experimental pulmonary tuberculosis.","volume":"89","author":"R Hernandez-Pando","year":"1996","journal-title":"Immunology"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3109\/10520298009067249","article-title":"The use of fluorescein diacetate and ethidium bromide as a stain for evaluating viability of mycobacteria.","volume":"55","author":"JL Jarnagin","year":"1980","journal-title":"Stain Technol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0028-3908(93)90096-L","article-title":"Thioridazine induces lipid peroxidation in myelin of rat brain.","volume":"32","author":"GS Dhaunsi","year":"1993","journal-title":"Neuropharmacology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1365-2249.2004.02454.x","article-title":"Transfer factors as immunotherapy and supplement of chemotherapy in experimental pulmonary tuberculosis.","volume":"136","author":"RA Fabre","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1086\/426453","article-title":"16alpha-Bromoepiandrosterone restores T helper cell type 1 activity and accelerates chemotherapy-induced bacterial clearance in a model of progressive pulmonary tuberculosis.","volume":"191","author":"R Hern\u00e1ndez-Pando","year":"2005","journal-title":"J Infect Dis"},{"key":"ref14","first-page":"264","article-title":"Hernandez Pando R, Orozco-Esteves H, Maldonado HA, et al. A combination of a transforming growth factor-beta antagonist and an inhibitor of cyclooxygenase is an effective treatment for murine pulmonary tuberculosis.","volume":"144","journal-title":"Clin Exp Immunol 2006;"},{"key":"ref15","first-page":"771","article-title":"The curative activity of thioridazine on mice infected with <italic>Mycobacterium tuberculosis<\/italic>.","volume":"21","author":"M Martins","year":"2007","journal-title":"In Vivo"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1177\/039463200902200318","article-title":"Immunological parameters to define infection progression and therapy response in a well-defined tuberculosis model in mice.","volume":"22","author":"JE de Steenwinkel","year":"2009","journal-title":"Int J Immunopathol Pharmacol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0140-6736(05)70196-3","article-title":"Clinical outcome of individualised treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort study.","volume":"365","author":"V Leimane","year":"2005","journal-title":"Lancet"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ijantimicag.2009.12.019","article-title":"Thioridazine cures extensively drug-resistant tuberculosis (XDR-TB) and the need for global trials is now!","volume":"35","author":"L Amaral","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1128\/JB.01857-07","article-title":"Nitrate enhances the survival of <italic>Mycobacterium tuberculosis<\/italic> during inhibition of respiration.","volume":"190","author":"CD Sohaskey","year":"2008","journal-title":"J Bacteriol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0924-8579(00)00343-5","article-title":"Enhancement of antibiotic activity against poly-drug resistant <italic>Mycobacterium tuberculosis<\/italic> by phenothiazines.","volume":"17","author":"M Viveiros","year":"2001","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"ref21","doi-asserted-by":"crossref","first-page":"e10069","DOI":"10.1371\/journal.pone.0010069","article-title":"A <italic>Mycobacterium tuberculosis<\/italic> sigma factor network responds to cell-envelope damage by the promising anti-mycobacterial thioridazine.","volume":"5","author":"NK Dutta","year":"2010","journal-title":"PLoS One"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1023\/A:1022061513581","article-title":"Effect of phenothiazines on protein kinase C- and calcium-dependent activation of peritoneal macrophages.","volume":"19","author":"V Hadjimitova","year":"2003","journal-title":"Cell Biol Toxicol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0924-8579(00)00199-0","article-title":"Comparative in vitro activity of phenothiazines against multidrug-resistant <italic>Mycobacterium tuberculosis<\/italic>.","volume":"16","author":"MV Bettencourt","year":"2000","journal-title":"Int J Antimicrob Agents"},{"key":"ref24","first-page":"259","article-title":"Clinical, biochemical and post mortem studies on a patient treated with chlorpromazine.","volume":"4","author":"FM Forrest","year":"1963","journal-title":"Revue Agressologie"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1176\/appi.ajp.158.11.1774","article-title":"Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death.","volume":"158","author":"AH Glassman","year":"2001","journal-title":"Am J Psychiatry"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2165\/11531850-000000000-00000","article-title":"Antimicrobials and the risk of torsades de pointes: the contribution from data mining of the US FDA Adverse Event Reporting System.","volume":"33","author":"E Poluzzi","year":"2010","journal-title":"Drug Saf"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1517\/14740338.1.2.121","article-title":"Cardiotoxicity of macrolides, ketolides and fluoroquinolones that prolong the QTc interval.","volume":"1","author":"PB Iannini","year":"2002","journal-title":"Expert Opin Drug Saf"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0012640","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T03:38:29Z","timestamp":1588995509000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0012640"}},"subtitle":[],"editor":[{"given":"Gary","family":"Maartens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2010,9,9]]},"references-count":27,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2010,9,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0012640","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,9]]}}}